Explore more publications!
Vatican Health Times
Got News to Share?

Vatican Health Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Vatican Health Times.

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

Press releases published on December 2, 2025

Clene to Provide CNM-Au8® ALS Program Update
December 2, 2025

Clene to Provide CNM-Au8® ALS Program Update

Indeterminate GlobeNewswire
Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 2, 2025

Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Conflicting Guidance and Rapid Innovation Leave Physicians Seeking Clarity in Relapsed/Refractory Multiple Myeloma
December 2, 2025

Conflicting Guidance and Rapid Innovation Leave Physicians Seeking Clarity in Relapsed/Refractory Multiple Myeloma

Indeterminate GlobeNewswire
New Data Presented at the Clinical Trials on Alzheimer’s Disease (CTAD) Conference 2025 Confirms Pharmacological Effect of LEQEMBI® (lecanemab-irmb) on Neurotoxic Aβ Protofibrils in CSF
December 2, 2025

New Data Presented at the Clinical Trials on Alzheimer’s Disease (CTAD) Conference 2025 Confirms Pharmacological Effect of LEQEMBI® (lecanemab-irmb) on Neurotoxic Aβ Protofibrils in CSF

Indeterminate GlobeNewswire
Publication relating to transparency notifications
December 2, 2025

Publication relating to transparency notifications

Indeterminate GlobeNewswire
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 2, 2025

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Verano Awarded Conditional License to Commence Vertical Cannabis Operations in Texas
December 2, 2025

Verano Awarded Conditional License to Commence Vertical Cannabis Operations in Texas

Indeterminate GlobeNewswire
Opus Genetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
December 2, 2025

Opus Genetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Black Diamond Therapeutics to Host Webcast Presentation Highlighting Silevertinib Phase 2 Clinical Trial Results and Program Update
December 2, 2025

Black Diamond Therapeutics to Host Webcast Presentation Highlighting Silevertinib Phase 2 Clinical Trial Results and Program Update

Indeterminate GlobeNewswire
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of November 30, 2025
December 2, 2025

Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of November 30, 2025

Indeterminate GlobeNewswire
FISHER HOUSE FOUNDATION RECEIVES “FOUR STARS” FOR 22nd YEAR FROM CHARITY NAVIGATOR, A+ FROM CHARITY WATCH
December 2, 2025

FISHER HOUSE FOUNDATION RECEIVES “FOUR STARS” FOR 22nd YEAR FROM CHARITY NAVIGATOR, A+ FROM CHARITY WATCH

Indeterminate GlobeNewswire
Hawai’i Cancer Care and American Oncology Network Open New Kahului Clinic
December 2, 2025

Hawai’i Cancer Care and American Oncology Network Open New Kahului Clinic

Indeterminate GlobeNewswire
Migraine Clinical Trial Pipeline Expands as 30+ Companies Driving Innovation in Oncology Therapeutics Space | DelveInsight
December 2, 2025

Migraine Clinical Trial Pipeline Expands as 30+ Companies Driving Innovation in Oncology Therapeutics Space | DelveInsight

Indeterminate GlobeNewswire
AMPS Achieves HITRUST e1 Certification, Solidifying Commitment to Data Security in Healthcare
December 2, 2025

AMPS Achieves HITRUST e1 Certification, Solidifying Commitment to Data Security in Healthcare

Indeterminate GlobeNewswire
Cosmos Health CEO Greg Siokas Adds 3,398,055 Shares Year-to-Date 2025 Following Continued November Purchases
December 2, 2025

Cosmos Health CEO Greg Siokas Adds 3,398,055 Shares Year-to-Date 2025 Following Continued November Purchases

Indeterminate GlobeNewswire
Quetzal Therapeutics Launches Phase III Clinical Trial of Oral QTX-2101 for Acute Promyelocytic Leukemia (APL)
December 2, 2025

Quetzal Therapeutics Launches Phase III Clinical Trial of Oral QTX-2101 for Acute Promyelocytic Leukemia (APL)

Indeterminate GlobeNewswire
LAMY Completes Strategic Acquisition of Cancer Therapy Innovator Exousia AI, Inc.
December 2, 2025

LAMY Completes Strategic Acquisition of Cancer Therapy Innovator Exousia AI, Inc.

Indeterminate GlobeNewswire
INVO Fertility Announces Pricing of $4.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules
December 2, 2025

INVO Fertility Announces Pricing of $4.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Indeterminate GlobeNewswire
Creative Medical Technology Holdings Announces World Health Organization Approval of “olastrocel” as INN for Lead Allogeneic Cell Therapy CELZ-201
December 2, 2025

Creative Medical Technology Holdings Announces World Health Organization Approval of “olastrocel” as INN for Lead Allogeneic Cell Therapy CELZ-201

Indeterminate GlobeNewswire
Longeveron Granted Canadian Patent for Method of Using Stem Cells to Treat Non-Ischemic Dilated Cardiomyopathy and Aging-related Frailty in Patients with Inflammaging
December 2, 2025

Longeveron Granted Canadian Patent for Method of Using Stem Cells to Treat Non-Ischemic Dilated Cardiomyopathy and Aging-related Frailty in Patients with Inflammaging

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions